Bilirubin Toxicity in the Auditory System

胆红素对听觉系统的毒性

基本信息

项目摘要

DESCRIPTION (provided by applicant): Brain damage and auditory dysfunction continue to be major complications of bilirubin toxicity despite advances in the treatment of hyperbilirubinemia (jaundice) in newborns. The spectrum of bilirubin damage ranges from classic kernicterus with hearing loss and deafness, which has recently reemerged due in part to the earlier discharge of newborns from hospitals, to more subtle damage, such as auditory neuropathy, isolated peripheral and central auditory dysfunction, and cognitive deficits. The incidence of auditory impairment due to bilirubin toxicity is difficult to relate to transient neonatal hyperbilirubinemia. In addition, the pathogenesis, sites of auditory dysfunction, and determinants of vulnerability and reversibility are still only partially understood despite decades of study. We have used non-invasive electrophysiology in combination with other techniques in the classic Gunn rat model of bilirubin encephalopathy to make sense of a complex and confusing historical literature regarding localization of damage in the auditory system. We have demonstrated reversibility of the pathophysiology, and have identified a potential molecular mechanism of the toxicity. We propose to extend our productive studies using noninvasive brainstem auditory evoked potentials (BAEPs), binaural BAEPs and a new unbound bilirubin (UB) blood test in the jaundiced Gunn rat. BAEP and UB changes that occur after bilirubin toxicity will be compared to biochemical and anatomical measures. We will evaluate hypothesis-driven interventions aimed at preventing and reversing bilirubin toxicity in young rats, and investigate subtle auditory sequelae in older animals. We will relate different patterns of biiirubin-induced auditory disorders to differences in the amount, duration, and the developmental timing of the bilirubin exposure, and define the kinetics of reversibility of the toxicity. Among many potential molecular mechanisms and markers, we have identified changes in expression of calcium/calmodulin-dependent kinase II and calcium binding proteins that seem to bear a consistent relationship with the pathophysiology and anatomy. We will now use these markers to investigate the pathogenesis of the selective damage and cell death due to bilirubin toxicity. The specific aims are all directed toward providing a cohesive and comprehensive characterization of the localization, susceptibility, reversibility, sequelae, and pathogenesis of auditory dysfunction due to bilirubin toxicity and its effect on normal developmental processes and outcomes. The findings of the proposed research should lead to improved noninvasive procedures for predicting, preventing, and treating the neurological and audiological complications of bilirubin toxicity in human newborns.
描述(申请人提供):脑损伤和听力障碍仍然是胆红素中毒的主要并发症,尽管新生儿高胆红素血症(黄疸)的治疗取得了进展。胆红素损伤的范围从典型的核黄体症伴听力损失和耳聋,最近重新出现,部分原因是新生儿较早出院,到更轻微的损伤,如听神经病,孤立的外周和中枢听觉功能障碍,以及认知障碍。胆红素毒性所致听力损害的发生率很难与一过性新生儿高胆红素血症有关。此外,尽管经过几十年的研究,但对听觉功能障碍的发病机制、位置以及易损性和可逆性的决定因素仍只有部分了解。在经典的Gunn大鼠胆红素脑病模型中,我们结合使用了无创电生理学和其他技术,以理解关于听觉系统损伤定位的复杂而令人困惑的历史文献。我们已经证明了病理生理学的可逆性,并确定了毒性的潜在分子机制。我们建议扩展我们的生产性研究,使用无创脑干听觉诱发电位(BAEP),双耳BAEP和一种新的无结合胆红素(UB)血液测试在黄斑性Gunn大鼠。胆红素中毒后BAEP和UB的变化将与生化和解剖学指标进行比较。我们将评估旨在预防和逆转幼年大鼠胆红素毒性的假说驱动的干预措施,并调查老年动物的细微听觉后遗症。我们将把胆红素引起的听力障碍的不同模式与胆红素暴露的量、持续时间和发育时间的不同联系起来,并定义毒性可逆性的动力学。在许多潜在的分子机制和标志物中,我们已经确定了钙/钙调蛋白依赖蛋白II和钙结合蛋白表达的变化,这些变化似乎与病理生理学和解剖学具有一致的关系。我们现在将使用这些标记物来研究胆红素毒性引起的选择性损伤和细胞死亡的发病机制。这些特定的目标都是为了提供一个连贯和全面的特征,描述由胆红素毒性引起的听觉功能障碍的定位、易感性、可逆性、后遗症和发病机制,以及它对正常发育过程和结果的影响。这项拟议的研究结果应该有助于改进预测、预防和治疗新生儿胆红素中毒的神经学和听力学并发症的非侵入性程序。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven Malcolm Shapiro其他文献

Steven Malcolm Shapiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven Malcolm Shapiro', 18)}}的其他基金

Dystonia in an Animal Model of Kernicterus
核黄疸动物模型中的肌张力障碍
  • 批准号:
    6821294
  • 财政年份:
    2004
  • 资助金额:
    $ 30.71万
  • 项目类别:
Dystonia in an Animal Model of Kernicterus
核黄疸动物模型中的肌张力障碍
  • 批准号:
    7097275
  • 财政年份:
    2004
  • 资助金额:
    $ 30.71万
  • 项目类别:
Dystonia in an Animal Model of Kernicterus
核黄疸动物模型中的肌张力障碍
  • 批准号:
    6940865
  • 财政年份:
    2004
  • 资助金额:
    $ 30.71万
  • 项目类别:
Dystonia in an Animal Model of Kernicterus
核黄疸动物模型中的肌张力障碍
  • 批准号:
    7266877
  • 财政年份:
    2004
  • 资助金额:
    $ 30.71万
  • 项目类别:
BILIRUBIN TOXICITY IN THE AUDITORY SYSTEM
胆红素对听觉系统的毒性
  • 批准号:
    6489512
  • 财政年份:
    1988
  • 资助金额:
    $ 30.71万
  • 项目类别:
BILIRUBIN TOXICITY IN THE AUDITORY SYSTEM
胆红素对听觉系统的毒性
  • 批准号:
    2125523
  • 财政年份:
    1988
  • 资助金额:
    $ 30.71万
  • 项目类别:
BILIRUBIN TOXICITY IN THE AUDITORY SYSTEM
胆红素对听觉系统的毒性
  • 批准号:
    3216705
  • 财政年份:
    1988
  • 资助金额:
    $ 30.71万
  • 项目类别:
BILIRUBIN TOXICITY IN THE AUDITORY SYSTEM
胆红素对听觉系统的毒性
  • 批准号:
    2125524
  • 财政年份:
    1988
  • 资助金额:
    $ 30.71万
  • 项目类别:
BILIRUBIN TOXICITY IN THE AUDITORY SYSTEM
胆红素对听觉系统的毒性
  • 批准号:
    3216709
  • 财政年份:
    1988
  • 资助金额:
    $ 30.71万
  • 项目类别:
BILIRUBIN TOXICITY IN THE AUDITORY SYSTEM
胆红素对听觉系统的毒性
  • 批准号:
    2125522
  • 财政年份:
    1988
  • 资助金额:
    $ 30.71万
  • 项目类别:

相似海外基金

Auditory Cortex Plasticity Following Deafness
耳聋后的听觉皮层可塑性
  • 批准号:
    478943
  • 财政年份:
    2023
  • 资助金额:
    $ 30.71万
  • 项目类别:
    Operating Grants
Functional and structural characterization of human auditory cortex using high resolution MRI
使用高分辨率 MRI 表征人类听觉皮层的功能和结构
  • 批准号:
    10728782
  • 财政年份:
    2023
  • 资助金额:
    $ 30.71万
  • 项目类别:
Evaluating probabilistic inferential models of learnt sound representations in auditory cortex
评估听觉皮层中学习的声音表征的概率推理模型
  • 批准号:
    BB/X013391/1
  • 财政年份:
    2023
  • 资助金额:
    $ 30.71万
  • 项目类别:
    Research Grant
CRCNS US-France Research Proposal: Neural computations of adaptive temporal integration in auditory cortex
CRCNS 美国-法国研究提案:听觉皮层自适应时间整合的神经计算
  • 批准号:
    2308725
  • 财政年份:
    2023
  • 资助金额:
    $ 30.71万
  • 项目类别:
    Standard Grant
Intracranial Electrophysiology & Anatomical Connectivity of Voice-Selective Auditory Cortex
颅内电生理学
  • 批准号:
    10747659
  • 财政年份:
    2023
  • 资助金额:
    $ 30.71万
  • 项目类别:
Functional Organization of Non-Primary Auditory Cortex
非初级听觉皮层的功能组织
  • 批准号:
    RGPIN-2022-05068
  • 财政年份:
    2022
  • 资助金额:
    $ 30.71万
  • 项目类别:
    Discovery Grants Program - Individual
Development of tinnitus suppression method by controlling excitation-inhibition balance in auditory cortex using bidirectional BMI and optogenetics
利用双向BMI和光遗传学控制听觉皮层兴奋抑制平衡开发耳鸣抑制方法
  • 批准号:
    22H03655
  • 财政年份:
    2022
  • 资助金额:
    $ 30.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Disinhibition and Hyperexcitability in Human Auditory Cortex
人类听觉皮层的去抑制和过度兴奋
  • 批准号:
    10432789
  • 财政年份:
    2022
  • 资助金额:
    $ 30.71万
  • 项目类别:
The role of AMPA receptors in critical period plasticity in the auditory cortex
AMPA 受体在听觉皮层关键期可塑性中的作用
  • 批准号:
    RGPIN-2018-06552
  • 财政年份:
    2022
  • 资助金额:
    $ 30.71万
  • 项目类别:
    Discovery Grants Program - Individual
Dynamic circuit motifs underlying multimodal interactions in primate auditory cortex
灵长类听觉皮层多模态相互作用的动态电路基序
  • 批准号:
    10586804
  • 财政年份:
    2022
  • 资助金额:
    $ 30.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了